The methylation level of ATF5 has been reported to be different in poorly differentiated glioma, well-differentiated glioma, and normal tissues, which suggested that aberrant methylation of ATF5 is connected with the pathophysiology of glioma (49). Here, ATF5 is linked to central nervous system cancer.